Research on ALCL is ongoing, with studies focusing on understanding the genetic and molecular basis of the disease. New therapies, including immunotherapy and novel targeted agents, are being explored in clinical trials. Additionally, research into the role of ALK inhibitors and other targeted therapies holds promise for improving treatment outcomes and reducing side effects.
